Meghmani Organics Limited has informed the Exchange about Transcript

Meghmani Organics reported FY26 standalone revenue of INR 2,091 crores (up 4% Y-o-Y) and EBITDA of INR 228.7 crores (up 27% Y-o-Y). Q4 FY26 was weak with EBITDA at INR 26.2 crores due to geopolitical headwinds (US tariffs, US-Iran war) causing raw material cost surges while realization remained stable. The Crop Protection segment (78% of revenue) achieved 15% EBITDA margin for FY26 but dropped to 9% in Q4, while the Pigments segment (22% of revenue) remains under pressure at ~3% EBITDA margin. Key developments include: a new 100% subsidiary in Brazil targeting the $15 billion agrochemical market, EcoVadis Silver Medal upgrade, and approval to manufacture Nano DAP/NPK/Zinc fertilizers at the Sanand facility (commercial production in Kharif season). The TiO2 plant remains suspended due to sulphuric acid prices spiking above INR 30/kg (normally below INR 5) after the anti-dumping duty was withdrawn. The company filed a scheme of amalgamation merging Kilburn Chemicals and Meghmani Crop Nutrition into the parent to achieve synergies. Debt stands at INR 528 crores standalone (0.30x D/E) and INR 722 crores consolidated. Management guided FY27 double-digit revenue growth in Crop Protection and reaffirmed long-term 15-17% EBITDA margin for the segment, expecting profitability to improve as cost-price gaps rationalize. Capex for FY27 will be minimal at INR 35-40 crores (routine only).